Amgen bought ChemoCentryx ChemoCentryx from 10/20/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.

ChemoCentryx

Review

Source:

{source} pictogram

investors.amgen.com

Vladimir Petenev

News editor

Write your comment first

News feed

Qiwi paid ₽1.773 billion for 79% of Realweb advertising agency

4/4/23 QIWI

Yandex introduced new smart home devices

4/4/23 YNDX

Sollers reported for 2022 according to RAS

4/4/23 SVAV

MTS reported for 2022 according to RAS

4/4/23 MTSS

Magnit will open up to 50 at-home plus stores

4/4/23 MGNT

Starbucks announced a quarterly dividend

4/4/23 SBUX

Monopoly Group will buy a controlling stake in Globaltruck

4/4/23 GTRK

Phosagro in Q1 increased production by 6%

4/4/23 PHOR

M.Video opens stores in a new format M.Compact

4/4/23 MVID

Novatek applied for a stake in Sakhalin-2

4/4/23 NVTK